1Winkelstein JA,Marino MC,Lederman HM,et al.X-linked agammaglobulinemia:report On anuntited states registry of 201 patients.Medcine (Baltimore),2006,85:193-202.
2Lederman HM.Winkelstein JA.X-linked agammaglobulinemia:an analysis of 96patients.Medicine(Baltimore),1985,64:145-156.
2Tsukada S, Saffran DC, Rawlings DJ, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell, 1993, 72:279-290.
3Futatani T, Miyawaki T, Tsukada S, et al. Deficient ex-pression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood, 1998, 91:595-602
4Sideras P, Smith CIE. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol, 1995, 59:135-197.
5Yip KL, Chan SY, Ip WK, et aL Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. Hum Mutat, 2000, 15:385-388.
6Kanegane H, Futatani T, Wang Y, et al. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by tlow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol, 2001, 108: 1012-1020.
7Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr, 2002, 141:566-571.
8Usui K, Sasahara Y, Tazawa R, et al. Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults. Respir Res, 2001,2:188-192.
9Plebani A, Soresina A, Rondelli R, et al. Clinical, immunological,and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin I mmunol,2002 , 104:221-230.
10Quinti I, Pierdominici M, Marziali M, et al. European surveillance of immunoglobulin safety-results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. Clin Immunol, 2002,104:231-236.
